Literature DB >> 25216692

A non-human primate model of aneurismal subarachnoid hemorrhage (SAH).

Ryszard M Pluta1, John Bacher, Boris Skopets, Victoria Hoffmann.   

Abstract

Aneurismal subarachnoid hemorrhage (SAH) is relatively rare form of hemorrhagic stroke, which produces significant social and medical challenges. As it affects people in their high productivity age and leaves 50 % of them dead and almost 70 % of survivors disabled, many of them severely, the reasons of such a dismal outcome have been intensively researched all over the world. Nevertheless, despite more than a half a century of clinical and scientific effort and dramatic improvement of surgical repair of aneurysms, the causes of poor outcome remain enigmatic. Introduction of numerous in vitro and in vivo models to study the unleashed by SAH mechanisms that injured the brain significantly advanced our understanding of biology of cerebral vessels, brain responses to intracranial pressure changes, and the presence of blood clot in subarachnoid space. One of the most important animal models that significantly contributed to those advances has been a non-human primate model introduced at the Bryce Weir laboratory in the University of Alberta, Canada, in 1984. Since then, this model, with some modifications, has been successfully used in several animal laboratories in the USA, Canada, and Japan. We present the model characteristics and describe in details medical, surgical, imagining techniques that we have used at the Surgical Neurology Branch of the National Institute of Neurological Disorders and Stroke from 1989.

Entities:  

Mesh:

Year:  2014        PMID: 25216692     DOI: 10.1007/s12975-014-0371-9

Source DB:  PubMed          Journal:  Transl Stroke Res        ISSN: 1868-4483            Impact factor:   6.829


  36 in total

Review 1.  Mechanisms of acute brain injury after subarachnoid hemorrhage.

Authors:  Fatima A Sehba; Joshua B Bederson
Journal:  Neurol Res       Date:  2006-06       Impact factor: 2.448

2.  Delayed ischaemic neurological deficits after subarachnoid haemorrhage are associated with clusters of spreading depolarizations.

Authors:  Jens P Dreier; Johannes Woitzik; Martin Fabricius; Robin Bhatia; Sebastian Major; Chistoph Drenckhahn; Thomas-Nicolas Lehmann; Asita Sarrafzadeh; Lisette Willumsen; Jed A Hartings; Oliver W Sakowitz; Jörg H Seemann; Anja Thieme; Martin Lauritzen; Anthony J Strong
Journal:  Brain       Date:  2006-10-25       Impact factor: 13.501

3.  Preventing vasospasm improves outcome after aneurysmal subarachnoid hemorrhage: rationale and design of CONSCIOUS-2 and CONSCIOUS-3 trials.

Authors:  R Loch Macdonald; Randall T Higashida; Emanuela Keller; Stephan A Mayer; Andy Molyneux; Andreas Raabe; Peter Vajkoczy; Isabel Wanke; Aline Frey; Angelina Marr; Sébastien Roux; Neal F Kassell
Journal:  Neurocrit Care       Date:  2010-12       Impact factor: 3.210

4.  Clazosentan (AXV-034343), a selective endothelin A receptor antagonist, in the prevention of cerebral vasospasm following severe aneurysmal subarachnoid hemorrhage: results of a randomized, double-blind, placebo-controlled, multicenter phase IIa study.

Authors:  Peter Vajkoczy; Bernhard Meyer; Stefan Weidauer; Andreas Raabe; Claudius Thome; Florian Ringel; Volker Breu; Peter Schmiedek
Journal:  J Neurosurg       Date:  2005-07       Impact factor: 5.115

5.  Aneurysmal subarachnoid hemorrhage: management strategies and clinical outcomes in a regional neuroscience center.

Authors:  Lisa M Flett; Colin S Chandler; David Giddings; Anil Gholkar
Journal:  AJNR Am J Neuroradiol       Date:  2005-02       Impact factor: 3.825

6.  Time course of vasospasm in man.

Authors:  B Weir; M Grace; J Hansen; C Rothberg
Journal:  J Neurosurg       Date:  1978-02       Impact factor: 5.115

7.  Safety and pharmacokinetics of sodium nitrite in patients with subarachnoid hemorrhage: a phase IIa study.

Authors:  Edward H Oldfield; Johanna J Loomba; Stephen J Monteith; R Webster Crowley; Ricky Medel; Daryl R Gress; Neal F Kassell; Aaron S Dumont; Craig Sherman
Journal:  J Neurosurg       Date:  2013-05-24       Impact factor: 5.115

8.  Subarachnoid hemorrhage and the distribution of drugs delivered into the cerebrospinal fluid. Laboratory investigation.

Authors:  Ryszard M Pluta; John A Butman; Bawarjan Schatlo; Dennis L Johnson; Edward H Oldfield
Journal:  J Neurosurg       Date:  2009-11       Impact factor: 5.115

9.  Pathogenetic role of no-reflow phenomenon in experimental subarachnoid hemorrhage in dogs.

Authors:  T Asano; K Sano
Journal:  J Neurosurg       Date:  1977-04       Impact factor: 5.115

10.  Early effects of experimental arterial subarachnoid haemorrhage on the cerebral circulation. Part II: Regional cerebral blood flow and cerebral microcirculation after experimental subarachnoid haemorrhage.

Authors:  T Trojanowski
Journal:  Acta Neurochir (Wien)       Date:  1984       Impact factor: 2.216

View more
  4 in total

1.  Animal Models for the Study of Subarachnoid Hemorrhage: Are We Moving Towards Increased Standardization?

Authors:  Serge Marbacher
Journal:  Transl Stroke Res       Date:  2016-01-12       Impact factor: 6.829

2.  Aneurysmal subarachnoid hemorrhage--status quo and perspective.

Authors:  Nima Etminan
Journal:  Transl Stroke Res       Date:  2015-04-11       Impact factor: 6.829

3.  What is early brain injury?

Authors:  Hidenori Suzuki
Journal:  Transl Stroke Res       Date:  2014-12-16       Impact factor: 6.829

4.  Alcohol consumption and risk of subarachnoid hemorrhage: A meta-analysis of 14 observational studies.

Authors:  Xiyang Yao; Kai Zhang; Jieyong Bian; Gang Chen
Journal:  Biomed Rep       Date:  2016-08-23
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.